| Literature DB >> 29034446 |
Ana M Ramos-Leví1, Andrés Sánchez-Pernaute2, Clara Marcuello3, Mercedes Galindo3, Alfonso L Calle-Pascual3,4, Antonio J Torres2, Miguel A Rubio3.
Abstract
We aimed to corroborate glycemic control after bariatric surgery (BS) using continuous glucose monitoring (CGM) and analyze if data could predict long-term outcome. We evaluated 24 of our patients with type 2 diabetes who underwent BS (12 Roux-en-Y gastric bypass, RYGB, and 12 single-anastomosis duodeno-ileal bypass with sleeve gastrectomy, SADI-S) and who were in remission after 18-24 months' follow-up. At this time, a CGM device was placed for 7 days. Patients were reevaluated thereafter for at least 5 years. Glucose variability (GV) was lower in patients after SADI-S and in the 18 patients who were still in remission after 5 years, and provided more information on long-term status than classical diabetes-related characteristics.Entities:
Keywords: Bariatric surgery; Diabetes mellitus; Diabetes remission; Glucose variability; Metabolic surgery; Obesity; Remission criteria; SADI-S; Type 2
Mesh：
Substances：
Year: 2017 PMID： 29034446 DOI： 10.1007/s11695-017-2960-7
Source DB: PubMed Journal: Obes Surg ISSN： 0960-8923 Impact factor: 4.129